GLP-1 Appetite Suppressants Linked to Deficits in Fiber, Vitamins, and Calories
A new exploratory study published in BMJ Nutrition Prevention & Health suggests that individuals using GLP-1 receptor agonists like Wegovy and Mounjaro may experience inadequate intake of key nutrients due to suppressed appetites and a lack of clinical dietary guidance.
🧠AI AnalysisPhoto: Medical Xpress
Key points
- Small exploratory study links GLP-1 drugs to low nutrient and calorie intake
- Widespread shortfalls observed in fiber, vitamin D, and iron consumption
- Participants reported limited clinical oversight and lack of tailored dietary guidance
Appetite-suppressing medications utilized for weight management and type 2 diabetes, such as Wegovy and Mounjaro, may contribute to insufficient consumption of essential nutrients and overall daily energy, according to preliminary research from a general practice in England. Researchers analyzed dietary recalls from 14 patients taking these treatments to evaluate their daily intake across 28 distinct nutrients compared against official U.K. government recommendations.
The observational findings suggest that average daily energy consumption among participants sat significantly below estimated requirements, with more than half of the group failing to reach two-thirds of their expected energy needs. Furthermore, the data indicate widespread shortfalls in specific dietary components: over three-quarters of the cohort consumed less than two-thirds of the recommended intake for fiber and vitamin D, while half fell short on iron. Every single participant failed to meet the daily benchmark of 400 grams of fruits and vegetables. However, average protein consumption remained robust, exceeding recommended benchmarks for nearly all evaluated individuals.
The study highlights a potential gap in clinical follow-up and nutritional monitoring for patients utilizing incretin-based therapies. Participants reported receiving minimal structured dietary advice from healthcare providers, often leaving them to navigate side effects, altered food enjoyment, and social eating anxieties independently. Because this was a small, exploratory study relying on self-reported dietary recalls, experts emphasize that larger clinical trials are necessary to confirm these patterns and establish appropriate nutritional frameworks.
What to know: Patients taking GLP-1 weight-loss medications may experience significant drops in calorie, fiber, and vitamin intake due to reduced appetite. Always consult a healthcare provider or registered dietitian before making major changes to your diet or treatment plan.
Source Medical Xpress — medicalxpress.com/news/2026-11-glp-weight-loss-drugs-linked.html ↗
Read next
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.